Arvinas Competitors and Similar CompaniesClear all
Lyell's competitors and similar companies include Foghorn Therapeutics.
 Foghorn Therapeutics Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors. | ||
Founding Date | Founding Date 2018 | Founding Date 2016 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations South San Francisco, US HQ Bothell, US Seattle, US | Locations Cambridge, US HQ Cambridge, US |
Employees | Employees 188 | Employees 1123% decrease |
Valuation ($) | Valuation ($) 243.3 m | Valuation ($) 452 m |
Financial | ||
Revenue (est.) | Revenue (est.) $36k (FY, 2025) | Revenue (est.) $30.9m (FY, 2025) |
Net income | Net income ($274.4m) (FY, 2025) | Net income ($74.4m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Foghorn Therapeutics
HQ
Cambridge, US
Employees
112↓ 3% decrease
Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors.
View company